Vascugenix, Inc.

Vascugenix is focused on developing innovative products to improve patient safety during interventional cardiology procedures.

Our Speed-Torque device uses a unique, patented design to improve the process of guidewire manipulation during Percutaneous Coronary and Peripheral Artery Interventions. The Speed-Torque provides physicians with the ability to manipulate catheter guidewires comfortably with one hand, allowing full attention on the patient and maintaining absolute control of the wire during the procedure. This shortens procedure time, decreases the amount of radiation both patients and physicians are exposed to, and decreases the risk of patient harm.

At this time, the Speed-Torque has received clearance from the FDA.

Company’s Keywords:

internal medicine, interventional cardiology, cardiovascular disease